Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Opioid Conversion Guidelines

Standard Conversion Factors

  • The Centers for Disease Control and Prevention (CDC) establishes that hydromorphone has a conversion factor of 4, meaning 1 mg of hydromorphone equals approximately 4 mg of morphine milligram equivalents (MME) 1, 2
  • Using this conversion, 20 mg hydromorphone is equivalent to approximately 80 mg morphine equivalent 1
  • Some clinical practice guidelines suggest a ratio closer to 5:1, which would yield approximately 100 mg morphine equivalent 3, 4

Route-Specific Considerations

  • The conversion ratio applies regardless of route (oral, IV, or subcutaneous) when comparing the same routes 3, 4
  • For IV to IV conversion, the 4:1 ratio is directly applicable 1
  • For oral to oral conversion, the same 4:1 to 5:1 ratio applies 3, 4

Critical Dosing Precautions When Converting

  • When converting a patient from hydromorphone to morphine, the calculated equivalent dose should be reduced by 25-50% to account for incomplete cross-tolerance between opioids 3, 4
  • If converting 20 mg hydromorphone, start with 40-60 mg morphine rather than the full calculated dose 3, 4
  • This dose reduction is essential to prevent overdose due to individual variability in opioid pharmacokinetics 1

Common Pitfalls to Avoid

  • The CDC recommends not using calculated MME doses directly for opioid conversion without dose reduction, as this can lead to fatal overdose 1, 2
  • Equianalgesic conversions are estimates only and cannot account for individual variability in genetics and pharmacokinetics 1
  • Always start lower than the calculated equivalent dose when switching opioids 3, 4
  • Monitor closely for signs of inadequate analgesia or opioid toxicity after conversion 3, 4

Special Population Considerations

  • The National Comprehensive Cancer Network recommends avoiding morphine entirely in patients with renal impairment and using alternative opioids instead 3, 4

REFERENCES

3

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

4

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010